1. Angrist B, Rotrosen J, Gershon S (1980) Differential effects of amphetamine and neuroleptics on negative versus positive symptoms in schizo- phrenia. Psychopharmacology 72: 17–19
2. Arana GW, Ornsteen ML, Kanter F, Friedman HL, Greenblatt DJ, Shader RI (1986) The use of benzodiazepines for psychotic disorders: a literature review and preliminary clinical findings. Psychopharmacol Bull 22: 77–87
3. Bannon MJ, Freeman AS, Chiodo LA, Bunney BS, Rom RH (1987) The electrophysiological and biochemical pharmacology of the mesolimbic and mesocortical dopamine neurons. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 19. Plenum Press, New York, pp 329–374
4. Baron JC, Martinot JL, Cambon TI, Boulenger JP, Poirier MF, Gaillard V, Bin J, Huret JD (1989) Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels. Psychopharmacology 99: 463–472
5. Beninger RJ (1983) The role of dopamine in loco-motor activity and learning. Brain Res Rev 6: 173–196